To systematically model PI3K pathway alterations and study p110 isoform dependencies in mCRPC, we evaluated a broad collection of patient-derived prostate cancer organoids (PDOs) established from metastatic tumor biopsies of mCRPC patients30. Here, PIK3CB is linked to prostate cancer.